Pharmica Health Hub

Acid reflux is one of the most common digestive complaints in the UK, but for many people it is more manageable than they realise. This week's Health Hub piece covers four lifestyle changes that NHS clinicians recommend as a first step: simple, practical adjustments that can make a real difference before medication is ever needed.

Acid reflux can be uncomfortable enough to disrupt your day, and omeprazole is one of the most common treatments people turn to for relief. Here's how it actually works, when to take it for the best effect, and what to know before you start.

Fungal nail infections are easy to miss at first, and many people only notice them when sandal season arrives. If your toenails have changed colour, thickened, or started to crumble, here's what to look out for and when it's worth treating.

Both Wegovy tablets and Rybelsus contain the same active ingredient. But they are different medicines and licensed for different conditions for patients in the UK. Find out more in our detailed comparison.

Wegovy tablets work differently from the injection, and getting the dosing routine right from day one makes a real difference. Here's everything you need to know about the titration schedule, how to take each tablet correctly, and why the fasting window isn't optional.

Both sumatriptan and rizatriptan belong to the same class of migraine medicines, but they work at different speeds and come in different forms. This guide explains how the two treatments compare across onset, dosage, side effects, and the practical situations where one might suit you better than the other.

Oral semaglutide tablets are a different delivery method for the same active ingredient as the Wegovy injection, but their side effect profile is distinct. This guide explains what the OASIS 4 trial data shows, how the tablet compares to the injection, and how to manage symptoms if they arise.

Wegovy semaglutide is now available in two forms - a once-weekly injection that has been used in the UK for several years, and a once-daily tablet that was approved in the US in late 2025 and received MHRA approval in the UK on 11 June 2026. If you're weighing up which option might suit you, this comparison covers what the clinical evidence actually shows.

This guide compares how Wegovy Semaglutide Tablets and Orlistat work, who each one suits, and what results to expect, so you can make an informed decision about the right treatment for you.

Wegovy semaglutide tablets are expected to arrive in the UK very soon, raising one big question for anyone considering them: what will they cost? This guide covers what we know about UK pricing, how the tablet compares to the Wegovy injection on cost, as well as the options that are available right now.